Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflo (R)) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study.

Neven, P. and Donders, G. and Moegele, M. and Lintermans, A. and BeIlen, G. and Ortmann, O. and Buchholz, S. (2012) Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflo (R)) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study. CANCER RESEARCH, 72 (24Supp): P2-12-06. ISSN 0008-5472, 1538-7445

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 27 May 2020 06:38
Last Modified: 27 May 2020 06:38
URI: https://pred.uni-regensburg.de/id/eprint/17596

Actions (login required)

View Item View Item